Spyre Therapeutics, Inc. (SYRE): 144 filed Mar 3, 2026

Form type

144

Filing date

Mar 3, 2026

Accession number

0001950047-26-002111

Filer

Spyre Therapeutics, Inc. (CIK 1636282)